The Department of Cardio-Thoracic
Surgery of The Fourth Affiliated Hospital Zhejiang University School of
Medicine originated from the Department of Cardio-Thoracic Surgery of The First
Affiliated Hospital, Zhejiang University School of Medicine, a key clinical
discipline of China's cardiovascular surgery field.
The Department of Cardio-Thoracic
Surgery of The First Affiliated Hospital, Zhejiang University School of
Medicine represents the earliest modern department integrating teaching,
scientific research and medical service in Zhejiang Province and a leading
discipline in the field of cardiothoracic surgery in and out of the province.
The department has walked ahead in the province and reached an advanced level
at home owing to its comprehensive strength, come out in front in the field of
adult cardiac surgery in the province and enjoyed a good reputation in China.
The department was appointed to give the master's degree program of Zhejiang
University in 2002 and to be the first to carry out the doctoral degree program
of cardiothoracic surgery of Zhejiang University in 2005, became one of the
first standardized training base for resident physicians of the National Health
Commission in 2007 and was appraised as a key national clinical specialty in
2011 (cardiac macrovascular surgery).
The academic leader Ni Yiming, a
chief physician, doctor of medicine and doctoral supervisor, is currently the
head of the Department of Cardio-Thoracic Surgery of The First Affiliated
Hospital, Zhejiang University School of Medicine, the head of the Center for
Heart Diseases and also the head of the heart-lung transplantation group of the
Key Research Lab of Multiple Organ Transplantation of the National Health
Commission, Zhejiang Organ Transplantation Center and Zhejiang Key Research Lab
for Organ Transplantation. He is a member of the Standing Committee of the
Chinese Society for Thoracic and Cardiovascular Surgery and the chairman of
Zhejiang Society for Thoracic and Cardiovascular Surgery. In April and November
2009, he was given the "Golden Knife Award", the highest award in
China's cardiothoracic surgery clinical field, and also "China's Physician
Award", the highest award in China's physician sector. By now, he has
trained over 30 doctoral and postgraduate students.
The executive director Feng Qiang is
a chief physician, doctor of surgery and a member of Zhejiang Society for
Thoracic and Cardiovascular Surgery. Our department has 2 attending physicians,
3 resident physicians and 1 cardiopulmonary bypass surgeon, all of whom have a
master's degree and above.
Introduction to the Department features
(1) High surgical safety;
(2) Advanced cardiac surgery in
China, and internationally advanced indicators;
(3) Combined transplantation of heart
and multiple organs, creating a number of records at home;
(4) Steadily improved cardiac
vascular surgery, being first-rate in China;
(5) Leading coronary artery bypass
grafting in the province, also advanced in China;
(6) Leading complex congenital
correction in the province's, also advanced in China;
(7) Leading ECMO technology in China;
(8) Advanced minimally invasive
surgery and thoracoscopic techniques in China;
(9) Standardized surgical treatment
of thoracic tumors.
Services:
(1) Minimally invasive thoracoscopic surgery
for benign and malignant thoracic tumors (such as lung cancer, esophageal
cancer, thymoma and schwannoma), with the proportion of minimally invasive
surgery as high as above 95%. By now, we have done over 300 minimally invasive
thoracoscopic operations for patients with lung cancer through advanced
technology in the province and thus accumulated rich experience in the
diagnosis and treatment of small pulmonary nodules and early lung cancer.
(2) Conventional surgical treatment and
minimally invasive thoracoscopic surgery of other thoracic diseases (such as
palmar hyperhidrosis, pneumothorax, bullae, pulmonary sequestration and chest
trauma).
(3) Conventional surgical treatment of
cardiovascular diseases such as valvular heart disease, congenital heart
disease, coronary heart disease and heart tumor resection, mature and leading
complex heart valve replacement, valvoplasty, off-pump coronary artery graft
bypass, minimally invasive tricuspid valve plasty and other technologies in the
province.
(4) Implantable venous access port, providing
convenience for patients receiving tumor chemotherapy and repeated intravenous
infusion.
